Skip to content

Clinical trials

Phase 3 Myocardial Infarction trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myocardial Infarction Phase: Phase 3 Country / region: Germany Clear all

36 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20041
20052
20067
20071
20082
20092
20102
20114
20135
20141
20161
20191
20202
20211
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Terminated7
Active, not recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
Stiftung Institut fuer Herzinfarktforschung3
AstraZeneca2
Boehringer Ingelheim2
GlaxoSmithKline2
Pfizer2
Sanofi2
A. M. Zeiher1
Asklepios proresearch1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myocardial Infarction36
Stroke12
Cardiovascular Diseases10
Acute Coronary Syndrome6
ST Elevation Myocardial Infarction6
Coronary Artery Disease5
Heart Failure4
Myocardial Ischemia3
Angina, Unstable2
Diabetes Mellitus2

Trials

Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.